The prion protein is a normal component of your cells, found on neurons and immune cells throughout the body, where it plays roles in nerve maintenance, copper handling, and cell signaling. The same protein becomes lethal when it refolds into an abnormal shape, one that recruits neighboring copies of the protein to misfold in the same way, building up into aggregates that destroy brain tissue. This transformation from helpful molecule to self-propagating pathogen is unlike anything else in biology, and understanding it has reshaped how scientists think about infectious disease, neurodegeneration, and even how proteins work.
What the Normal Prion Protein Does
The healthy version of the prion protein, often called PrPC (the “C” stands for cellular), sits on the outer surface of many cell types. It is anchored to the cell membrane and is especially abundant in the brain, but it shows up far beyond the nervous system. Studies mapping its distribution in adult mice found high levels in small-diameter sensory nerves, sympathetic ganglia, antigen-presenting immune cells, and subsets of lymphocytes throughout the skin, gut, and airways.1PubMed. Selective expression of prion protein in peripheral tissues of the adult mouse In human blood, PrPC appears on virtually all major cell types except eosinophils.2PubMed. Comparative analysis of normal prion protein expression on human, rodent, and ruminant blood cells by using a panel of prion antibodies
Its exact function has been debated for decades, but several roles have emerged with good evidence. One of the best-supported is copper handling. PrPC binds copper ions in a highly conserved stretch of the protein, and researchers believe it acts as a sensor for copper levels and free-radical stress at synapses, triggering calcium signals that adjust how neurons communicate.3PubMed. Cellular prion protein function in copper homeostasis and redox signalling at the synapse4PubMed Central. Copper and the prion protein: methods, structures, function, and disease Think of it as a combination smoke detector and thermostat for oxidative conditions around nerve connections.
Another critical job is helping maintain the insulating sheath around peripheral nerves. When researchers deleted the prion protein gene in mice, the animals developed a chronic loss of peripheral nerve myelin. The key detail: the problem originated in neurons, not in the cells that actually form the myelin wrapping. Mice that expressed PrPC only in neurons were protected, while mice that expressed it only in the wrapping cells were not.5PubMed. Axonal prion protein is required for peripheral myelin maintenance This means the protein acts as a signal from the nerve fiber telling its support cells to keep the insulation intact. Interestingly, when nerves were crushed and had to regenerate, PrPC turned out to be unnecessary for repair, suggesting it is specifically a maintenance signal rather than a construction signal.6PLOS ONE. The prion protein is not required for peripheral nerve de- and remyelination after crush injury
The Shape Shift That Turns a Normal Protein Deadly
The healthy prion protein is rich in coiled, spring-like structures called alpha-helices. Measurements using infrared spectroscopy showed that PrPC is about 42% alpha-helix and only about 3% beta-sheet, which is a flat, stacked arrangement.7PubMed Central. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins The disease-causing form, PrPSc (“Sc” for scrapie, the sheep disease where it was first studied), flips that ratio dramatically: roughly 43% beta-sheet and 30% alpha-helix. The amino acid sequence stays the same. What changes is the three-dimensional fold.
This matters because the flat beta-sheet form is sticky. Molecules in this conformation stack against each other and resist the enzymes that normally break down worn-out proteins. The result is aggregates that accumulate in the brain, forming the spongy holes visible under a microscope that give these diseases their clinical name: transmissible spongiform encephalopathies.
The conversion process appears to involve a partially unfolded intermediate. Under mildly acidic conditions or in the presence of certain salts, the normal protein can begin to unfold and then refold into the beta-sheet-rich shape, clumping into fibers that resist digestion.8PubMed. On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein Once a misfolded seed exists, it acts as a template: newly recruited normal protein copies its abnormal fold.9PubMed Central. Genesis of tramsmissible protein states via deformed templating This is the heart of the “protein-only hypothesis,” the once-controversial idea that a protein can be its own infectious agent without any DNA or RNA.10PubMed Central. Prion disease and the ‘protein-only hypothesis’
Human Prion Diseases
Human prion diseases are rare but uniformly fatal. About 85 to 90% of cases are sporadic, meaning the misfolding appears to start spontaneously with no known trigger. About 10 to 15% are genetic, caused by inherited mutations in the prion protein gene. A small number are acquired through exposure to infected tissue.11PubMed. Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis Despite sharing the same underlying mechanism, these diseases produce strikingly different symptoms depending on which mutation is present and which version of the protein the person carries at a common genetic position called codon 129.
The clearest illustration of this is the mutation at codon 178. When that mutation sits on a chromosome that also codes for methionine at codon 129, the result is fatal familial insomnia, a disease that attacks the thalamus and destroys the ability to sleep. The same codon 178 mutation paired with valine at codon 129 instead produces a subtype of familial Creutzfeldt-Jakob disease, which looks clinically like rapid-onset dementia.12PubMed. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism Same gene, same mutation, radically different disease, all depending on a single nearby DNA variant. Prion diseases show more phenotypic variety than almost any other group of neurodegenerative conditions.
Gerstmann-Sträussler-Scheinker syndrome, another genetic prion disease, tends to start earlier in life than most genetic CJD cases and progresses more slowly, sometimes lasting years rather than months.13PubMed Central. Genetic Prion Disease: Insight from the Features and Experience of China National Surveillance for Creutzfeldt-Jakob Disease It typically presents with progressive difficulty walking and coordinating movements before cognitive decline sets in, which can make early diagnosis tricky.
How the Brain Is Damaged
The accumulation of misfolded prion protein is clearly central to brain destruction, but the mechanism is not as simple as toxic aggregates piling up and crushing neurons. Microglia, the brain’s resident immune cells, play a surprisingly double-edged role. In a healthy brain, microglia clear debris and fight infection through inflammatory signaling. During prion disease, they ramp up inflammation through a pathway controlled by a molecule called NF-κB. You might expect that blocking this inflammatory response would make things worse by removing the brain’s cleanup crew. The opposite is closer to the truth, but with a twist.
When researchers knocked out NF-κB signaling specifically in microglia of prion-infected mice, those animals actually died faster, with an average survival of about 123 days compared to 157 days in normal mice.14PLOS Pathogens. Microglia-specific NF-κB signaling is a critical regulator of prion-induced glial inflammation and neuronal loss These mice lost hippocampal neurons earlier, even though they accumulated less misfolded prion protein overall at their terminal stage. The finding suggests that microglial inflammation, while damaging, also performs some protective housekeeping. Remove it entirely and the brain loses neurons even faster. The ideal treatment, if one existed, would need to fine-tune the immune response rather than simply silencing it.
Animal Prion Diseases and Environmental Persistence
Prion diseases in animals have had enormous economic and public-health consequences. The bovine spongiform encephalopathy (BSE, or “mad cow disease”) epidemic of the 1980s and 1990s prompted global bans on feeding ruminant-derived meat and bone meal back to cattle, and those bans have largely brought the disease under control.15Animal Diseases. Classical bovine spongiform encephalopathy and chronic wasting disease: two sides of the prion coin
Chronic wasting disease (CWD) in deer, elk, moose, and reindeer is a different story. CWD spreads through saliva, urine, feces, and even decomposing carcasses, and it has been confirmed in at least 26 U.S. states, three Canadian provinces, South Korea, and parts of Scandinavia.16PubMed Central. Chronic Wasting Disease in Cervids: Implications for Prion Transmission to Humans and Other Animal Species Experiments with mule deer showed that animals could contract CWD simply by living in a paddock where an infected deer had died and decomposed, or even in a paddock contaminated only by residual excreta.17PubMed Central. Environmental Sources of Prion Transmission in Mule Deer
Part of what makes CWD so hard to contain is the remarkable durability of prions in the environment. Misfolded prion protein binds tightly to common soil minerals, and that binding can actually increase the efficiency of oral transmission. Standard chemical disinfectants that would destroy most pathogens may not work when prions are bound to clay; the mineral appears to physically shield the protein from inactivation.18PubMed. Chemical Inactivation of Prions Is Altered by Binding to the Soil Mineral Montmorillonite Prions can remain infectious in soil for years, which is a headache for wildlife managers trying to prevent spread through contaminated land.
Why Prions Do Not Jump Easily Between Species
Despite their ability to self-replicate, prions do not infect every species equally. The “species barrier” is real and has been one of the central puzzles of prion biology. When prions from one species are introduced into another, infection often fails or takes far longer to develop. Research using yeast as a model system demonstrated that the protein sequence of the host, rather than anything about the host cell’s internal environment, is the primary gatekeeper.19PubMed Central. Contributions of the Prion Protein Sequence, Strain, and Environment to the Species Barrier
The prion protein’s overall shape is broadly similar across mammals, but small differences in the amino acid sequence create subtle structural variations that determine which misfolded conformations a given species’ protein can be forced into.20PubMed. Structural factors underlying the species barrier and susceptibility to infection in prion disease Think of it like a lock-and-key system: the template needs to fit well enough to force the new copy into the same shape. If the amino acid differences are too great, the template cannot grip the new protein effectively, and conversion stalls. Different prion “strains,” which are really different misfolded conformations of the same protein, add another layer. Structural comparisons of two mouse-adapted prion strains revealed distinct folding patterns within the individual rungs of the prion fiber, providing a physical basis for why different strains produce different disease patterns even within the same species.21PubMed Central. A structural basis for prion strain diversity
This barrier is reassuring for CWD specifically: so far, no human case of prion disease has been traced to deer or elk. But barriers can be leaky rather than absolute, and the continued geographic expansion of CWD means more people are exposed over time, which is why surveillance remains a priority.
Diagnosing Prion Disease
For decades, the only definitive way to diagnose a prion disease was to examine brain tissue after death. That changed with the development of RT-QuIC, a lab technique that exploits the very property that makes prions dangerous: their ability to convert normal protein into the misfolded form. A tiny sample of cerebrospinal fluid from a patient is mixed with normal recombinant prion protein. If misfolded seeds are present, they trigger a chain reaction of conversion, and the resulting aggregates are detected with a fluorescent dye in real time.22PubMed Central. Real-time quaking-induced conversion: a highly sensitive assay for prion detection
The test’s accuracy is striking. The UK National CJD Research and Surveillance Unit reports a sensitivity of 92% and specificity of 100% for sporadic CJD.23PubMed. RT-QuIC: a new test for sporadic CJD A broader assessment across all prion disease types found overall sensitivity of about 90% and specificity near 99%.24PubMed. Diagnosis of prion diseases by RT-QuIC results in improved surveillance The same principle works for animal prion diseases including scrapie, CWD, and BSE, making it a versatile tool for both clinical medicine and wildlife surveillance.22PubMed Central. Real-time quaking-induced conversion: a highly sensitive assay for prion detection
Iatrogenic Transmission and the Decontamination Problem
A small but troubling number of human prion disease cases have been traced to medical procedures. More than 490 incidents of iatrogenic transmission have been documented worldwide, most linked to contaminated growth hormone preparations or dura mater grafts used in neurosurgery.25PubMed Central. Human prion diseases: surgical lessons learned from iatrogenic prion transmission In the UK alone, 77 cases were attributed to iatrogenic routes, with human-derived growth hormone accounting for the majority.26Journal of Hospital Infection. Managing the risk of iatrogenic transmission of Creutzfeldt–Jakob disease in the UK Growth hormone is now produced synthetically, which eliminated that route, but the broader concern about surgical instruments persists.
Prions are extraordinarily resistant to standard sterilization. Autoclaving at typical hospital settings, chemical disinfectants, and even formaldehyde do not reliably destroy them. Laboratory studies have shown that standard decontamination procedures may fail to fully remove infectivity from prion-contaminated instruments.25PubMed Central. Human prion diseases: surgical lessons learned from iatrogenic prion transmission Hospitals in countries with active prion surveillance now follow enhanced protocols for instruments used in neurosurgery on suspected cases, sometimes quarantining or destroying them entirely rather than attempting reuse.
The Search for Treatments
No approved therapy exists for any human prion disease, but the most promising experimental approach targets the root of the problem: cutting off the supply of normal prion protein so the misfolded form has nothing to convert. Antisense oligonucleotides (ASOs), short synthetic DNA-like molecules that intercept the genetic instructions before the protein is made, have shown dramatic results in mice. When given early after infection, one ASO extended survival by 76% and delayed the onset of clinical signs by nearly double.27PubMed Central. Antisense oligonucleotides extend survival of prion-infected mice Even when treatment was delayed until a time point analogous to early symptomatic disease, the same ASO still extended survival by 55% and slowed the progression of symptoms once they appeared.
Earlier work had shown the basic principle: infusing an ASO directly into the brain of prion-infected mice starting just one day after infection prolonged incubation by almost two months.28Molecular Therapy – Nucleic Acids. Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice Follow-up studies confirmed that the benefit held across different prion strains and at various stages of disease.29Nucleic Acids Research. Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints This work has moved toward human trials, though delivering drugs into the central nervous system remains a significant practical hurdle.
Immunotherapy is another avenue, but it faces a fundamental obstacle: your immune system treats prion protein as “self” because it is a normal part of your body. Generating antibodies against it means breaking immune tolerance, which is inherently risky.30Nature Reviews Neurology. Immunotherapy in prion disease DNA-based vaccines have succeeded in producing anti-prion antibodies in mice and even delayed disease, but also caused some harmful side effects.31PubMed Central. DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge A monoclonal antibody called PRN100 was tested in the first human trial on CJD patients, offering a glimmer of hope that passive immunotherapy could eventually contribute to treatment, but results remain preliminary.32PubMed Central. Prion therapeutics: Lessons from the past
Prion-Like Behavior in Alzheimer’s and Parkinson’s Disease
One of the most consequential ideas to emerge from prion research is that other neurodegenerative diseases borrow from the same playbook. The tau protein in Alzheimer’s disease and the alpha-synuclein protein in Parkinson’s disease both appear to spread through the brain in a prion-like fashion: misfolded seeds travel from one neuron to the next along connected pathways and corrupt the normal versions of their respective proteins through templated misfolding.33PubMed. Tau Prion-Like Propagation: State of the Art and Current Challenges
Experimental evidence has firmed up this parallel. Injecting aggregated amyloid-beta or tau into mouse brains can seed pathology that then spreads along neuronal connections. And in a striking natural experiment, some patients who received contaminated growth hormone or dura mater grafts and later developed CJD also showed amyloid-beta pathology characteristic of Alzheimer’s, suggesting that amyloid-beta aggregates were transmitted alongside prions.34PubMed. The prion-like propagation hypothesis in Alzheimer’s and Parkinson’s disease These diseases are not infectious in the way CJD can be, but the molecular mechanism of spread within an individual brain shares deep similarities with prion propagation.
Prions as Beneficial Elements in Other Organisms
The prion concept extends beyond disease entirely. In fungi, particularly yeast, certain proteins adopt self-propagating conformations that function as heritable switches, changing how cells behave without altering their DNA. These fungal prions act as beneficial genetic elements, allowing populations to generate phenotypic diversity quickly in response to environmental stress.35Nature Reviews Genetics. Prions as adaptive conduits of memory and inheritance The same type of self-templating protein folding that kills neurons in a mammalian brain serves as a bet-hedging strategy in microbes, helping some individuals in a population survive conditions that would wipe out genetically identical neighbors.36Trends in Cell Biology. Prions and prion-like mechanisms: amyloid and beyond
This broader view suggests that prion-like mechanisms are ancient and widespread, and that disease-causing prions in mammals represent a catastrophic misfire of a mechanism that evolution has found useful in other contexts. It is a reminder that biology frequently recycles the same molecular trick for radically different purposes, and that the line between functional and pathological can be disturbingly thin.